Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sedation of Remazolam in Combination With Afentanil in Non-intubated Thoracoscopic Pulmonary Surgery: a Single-blind, Randomized, Controlled Trial

NCT06810843 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT06810843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sedation of Remazolam in Combination With Afentanil in Non-intubated Thoracoscopic Pulmonary Surgery: a Single-blind, Randomized, Controlled Trial
Lead sponsor
Qianfoshan Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
December 31, 2027
Enrollment
390 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary nodule cm